Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Dapagliflozin in Children With Proteinuria

NCT07204743 is registered in ClinicalTrials.gov with Al-Quds University as lead sponsor.

NCT NCT07204743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07204743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Dapagliflozin in Children With Proteinuria
Lead sponsor
Al-Quds University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 15, 2025
Completion date
August 31, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dapagliflozin (forxiga), pediatric kidney disease, proteinuric diseases, sglt 2 inhibitors